A nurse holds vials of AstraZeneca vaccine against COVID-19 during a vaccination campaign at WiZink indoor arena in Madrid, Spain, Friday, April 9, 2021. THE CANADIAN PRESS/AP/Manu Fernandez

A nurse holds vials of AstraZeneca vaccine against COVID-19 during a vaccination campaign at WiZink indoor arena in Madrid, Spain, Friday, April 9, 2021. THE CANADIAN PRESS/AP/Manu Fernandez

Several provinces lower age eligibility for AstraZeneca: at look at the vaccine

Ontario, Manitoba and Alberta are decreasing the age range from the recommended 55+ NACI set

Several provinces are lowering their minimum age requirement for the Oxford-AstraZeneca vaccine, allowing those 40-and-older to receive the jab as unruly spread of COVID-19 continues in their jurisdictions.

Ontario, Manitoba and Alberta are decreasing the age range from the recommended 55+ that the National Advisory Committee on Immunization set last month.

The NACI guidelines came about as Canada and other countries investigated possible links to rare instances of blood clots seen in a small minority of AstraZeneca recipients.

Those events continue to be an exceedingly rare side effect of the vaccine, with Canada reporting twocases out of more than 700,000 doses administered.

Here’s what we know about the AstraZeneca vaccine:

WHO IS ELIGIBLE TO GET IT?

As of Tuesday, people 40 years of age and older will be able to get the AstraZeneca jab in Ontario and Alberta. Manitoba said Monday that it, too, was offering the vaccine to those over age 40.

Health Canada had allowed the use of the vaccine for those 18 and up when it approved AstraZeneca in February, an authorization that has not changed.

Health Minister Patty Hajdu said in a press conference Sunday that provinces and territories were “free to use AstraZeneca in any aged population over 18.”

NACI had not updated its minimum age guidance for AstraZeneca as of Monday morning.

Ontario, Manitoba and Alberta’s move to a lower age range comes amid mounting pressure to expand eligibility as a third wave devastates parts of the country.

Alberta had the highest rate of active COVID-19 cases in Canada as of Sunday, while Ontario had reported an average of more than 4,300 new daily cases over the past week.

Concern around the rare clotting events has led to some hesitancy around AstraZeneca, with many eligible residents opting to wait for a jab from Pfizer-BioNTech or Moderna instead. As the COVID situation worsens in parts of the country, however, experts advise against waiting for another vaccine.

WHAT DO WE KNOW ABOUT THE BLOOD CLOT ISSUE?

The European Medicines Agency said earlier this month it found a possible link to very rare cases of unusual blood clots with low platelet counts in AstraZeneca recipients, usually happening within two weeks of getting the shot.

The global frequency of the blood clot disorder, known as vaccine-induced immune thrombotic thrombocytopenia or VITT, has been estimated at about one case in 100,000 to 250,000 doses.

Data published in the online journal Science last week said there were at least 222 suspected cases reported in Europe — out of 34 million people who received their first dose. More than 30 people have died.

Experts say the risk of developing blood clots due to COVID-19 is much higher, and they encouragepeople to accept the first vaccine they’re offered.

The EMA says symptoms to watch for include: shortness of breath, chest pain, swelling in the leg, persistent abdominal pain, persistent headaches and blurred vision or tiny blood spots under the skin beyond the injection site. The clotting issue has been treatable when caught early.

VIDEO: ‘Extremely, extremely rare’ blood clots ‘may be linked’ to AstraZeneca, Health Canada says

HOW EFFECTIVE IS ASTRAZENECA IN PREVENTING COVID INFECTIONS?

Data from clinical trials showed AstraZeneca was 62 per cent effective in preventing COVID-19 infections, but it prevented death and hospitalization in all participants who got the virus after receiving the vaccine.

Efficacy was a major talking point when AstraZeneca was first approved, with some comparing it to the 95 per cent efficacy shown in vaccine trials from Pfizer and Moderna.

But experts have stressed that all the authorized vaccines offer excellent protection against severe disease, hospitalization and death.

Real-world data may also suggest the efficacy of AstraZeneca’s vaccine increases over a longer time interval between the first and second shot. Clinical trials used a four-week span between doses but some countries have been delaying second doses by several weeks. In Canada, many provinces have opted to delay the second dose by four months.

HOW DOES THE VACCINE WORK?

All of the approved COVID-19 vaccines train the body to recognize the spike protein that coats the outer surface of the coronavirus.

AstraZeneca — a non-replicating viral vector vaccine — uses a harmless version of a cold virus as a vessel to give our cells the instructions they need to make the coronavirus’s spike protein.

The immune system recognizes the protein and makes antibodies, which then allow us to fend off attack if exposed in the future.

Experts say it takes a couple of weeks for the body to build up some level of immunity with any of the vaccines.

Some may see outward signs of an immediate immune response to the inoculation — the body’s way of preparing for what it perceives as an attack by the virus. This can cause side effects usually seen with other vaccines, including pain at the injection site, redness, swelling and even fever, but experts say that means the vaccine is working.

WHAT ARE THE ADVANTAGES TO THIS VACCINE?

The AstraZeneca vaccine can be shipped and stored at regular refrigerator temperature, unlike those by Pfizer-BioNTech and Moderna, which need colder storage temperatures.

That’s why they’ve been primarily used in pharmacies across the country, rather than large vaccine clinics.

From a global vaccination standpoint, the low cost of AstraZeneca’s vaccine — about US$4 per dose — gives it another advantage. AstraZeneca, which says it aims to manufacture up to three billion doses in 2021, has pledged to make their product available at cost around the world until at least July.

The Canadian Press


Like us on Facebook and follow us on Twitter.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Supporters gather during a rally against measures taken by government and health authorities to curb the spread of COVID-19 at the Whistle Stop cafe in Mirror Alta, on Saturday May 8, 2021. The Whistle Stop was shut down by AHS for not complying with COVID-19 rules. THE CANADIAN PRESS/Jason Franson
Police hand out tickets to dozens leaving anti-lockdown protest in Alberta

Hundreds gathered outside the Whistle Stop Café in the hamlet of Mirror, Alta.

People line up outside an immunization clinic to get their Oxford-AstraZeneca COVID-19 vaccine in Edmonton, Tuesday, April 20, 2021. Alberta leads the Prairie provinces in being the first to take COVID-19 vaccine bookings for pre-teens. THE CANADIAN PRESS/Jason Franson
Alberta leads Prairie provinces in accepting COVID vaccine bookings for pre-teens

The province begins accepting appointments for kids as young as 12 starting today

FILE - In this March 3, 2021, file photo, a vial of the Johnson & Johnson COVID-19 vaccine is displayed at South Shore University Hospital in Bay Shore, N.Y. (AP Photo/Mark Lennihan, File)
Johnson & Johnson COVID vaccine can be given to adults 30+ who can’t wait for mRNA: NACI

Panel says single shot vaccine can be especially useful for populations unable to return for second shot

Alberta’s environment department has known for years that toxins from old coal mines are contaminating populations of the province’s official animal, the bighorn sheep. THE CANADIAN PRESS/Craig Bihrl
Alberta government knew bighorn sheep contaminated with coal mine selenium, scientist says

Jeff Kneteman says Alberta Environment has known about the problem in bighorn sheep for years

Prime Minister Justin Trudeau receives his COVID-19 AstraZeneca vaccination in Ottawa, Friday, April 23, 2021. THE CANADIAN PRESS/Adrian Wyld
75% of Canadians need 1st vaccine dose to have more normal summer: Trudeau

The country is on track to hit a major milestone on the road to COVID-19 herd immunity Tuesday, with 40% vaccinated with a 1st dose

A vial of the AstraZeneca COVID-19 vaccine.THE CANADIAN PRESS/Carlos Osorio
Alberta to stop giving first doses of AstraZeneca COVID-19 shot as supply dwindles

There aren’t any confirmed shipments of AstraZeneca coming, and the province only has 8,400 doses of it left

Winnipeg Jets’ Andrew Copp (9) and Edmonton Oilers goaltender Mike Smith (41) watch an incoming shot during second period NHL action in Winnipeg, Monday, April 26, 2021. THE CANADIAN PRESS/Fred Greenslade
‘Very jealous’: Canadian teams can’t take advantage of NHL’s relaxed COVID-19 rules

League eased some tight COVID-19 health and safety protocols over the weekend for fully vaccinated clubs

File photo
Arrest made for armed robbery in Millet, Wetaskiwin RCMP continue to investigate

Wetaskiwin RCMP are investigating an armed robbery took place May 4, 2021 in Millet, Alta.

Dr. Karina Pillay, former mayor of Slave Lake, Alta., is shown at her medical clinic in Calgary on Friday, April 16, 2021. THE CANADIAN PRESS/Jeff McIntosh
10 years later: Former Slave Lake mayor remembers wildfire that burned through town

Alberta announced in 2011 that an unknown arsonist had recklessly or deliberately ignited the forest fire

The body of Brenda Ware, 35, was found along Highway 93 in Kootenay National Park on Thursday, May 6, 2021. (RCMP handout)
RCMP ask for tips after woman travelling from Alberta found dead in B.C. park

Brenda Ware was found along Highway 93 in the park, 54 kilometres north of the town of Radium

Most Read